Robert Southworth Searle

Star Asia Management LLC (Investment Management) (Star Asia) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Mount Laurel, New Jersey. The firm was founded by Malcolm MacLean and Taro Masuyama in 2006 as Star Asia Management Ltd. Star Asia provides investment management services to real estate funds that primarily invest in Japanese and other Asian commercial real estate and real estate related investments.

BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri.

Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander.

Star Asia Group LLC engages in Investment management business. The company was founded by Malcolm F. MacLean ? and Taro Masuyama on 2007 and is headquartered in Tokyo, Japan.

Get Help operates as a human and data-driven central solution that helps the helpers do their jobs. The firm helps caseworkers, service-providers or individuals experiencing homelessness. The company was founded by Anthony Greco and is headquartered in Hollywood, CA.

Star Asia Management LLC engages in the provision of investment advisory and management services. The company is headquartered in Wilmington, DE.

Allies For Every Child, Inc. provides child care services. The private company is based in Culver City, CA. The company was founded by Lezlie Johnson. The CEO is Heather Carrigan.

Bonum Therapeutics, Inc. is a privately held American company that focuses on generating a new class of therapeutics based on a proven technology platform. Bonum Therapeutics is based in an undisclosed location and was founded in 2022 by the Good Therapeutics team. The company's technology utilizes principles of allosteric regulation to create highly active and less toxic medicines, which can be applied to a wide range of therapeutic areas, including oncology, autoimmunity, metabolic disorders, and pain management. The company's molecules combine a sensor component directed against a specific biological marker and a therapeutic component. The company is backed by a group of leading venture investors, including Codon Capital, Roche Venture Fund, RiverVest Venture Partners, 3x5 Partners, Digitalis Ventures, and Vivo Capital. The company was founded by John Mulligan, who has been the CEO since incorporation.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri.

Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO.

Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA.

Adarza BioSystems, Inc. develops and manufacturers a multiplex immunoassay technology that can identify proteins and genetic markers in medical specimens. The firm operates as a medical diagnostics company which also develops a rapid and label-free biological assay platform for measuring clinical and point-of-care samples and also its technology allows hundreds of tests to be run simultaneously on a single chip. The company was founded by Benjamin L. Miller, Randolph R. Henke, Terry Gronwall and Christopher C. Striemer in 2008 and is headquartered in St. Louis, MO.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Good Therapeutics, Inc. operates as a biotechnology company. It develops "context-dependent" protein drugs that sense biomarkers and respond with a therapeutic activity. The company was founded by John Mulligan in 2016 and is headquartered in Seattle, WA.